Total R&D costs of select cancer drugs 2017
This statistic shows the total cost of research and development (R&D) for select cancer drugs that were on the market as of 2017. Alexion Pharmaceuticals' drug Eculizumab had a total R&D cost of 817.6 million U.S. dollars since R&D start in January 1992.